Clinical Trial Detail

NCT ID NCT02095184
Title GCC 1366 Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients
Recruitment Recruiting
Gender female
Phase Phase 0
Variant Requirements yes
Sponsors University of Maryland
Indications

Her2-receptor negative breast cancer

Therapies

Anastrozole

Letrozole

Age Groups: adult senior

Additional content available in CKB BOOST